Answer
Mavacamten has an estimated oral bioavailability of approximately 85% within the clinical dose range.
Sources for this answer
- Mavacamten BMS 2.5 mg, 5 mg, 10 mg, 15 mg hard capsulesBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 6Document updated
Sources checked